Additional file 1 of First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutations

Authors :: Wang, Xuan
Luo, Zhiguo
Chen, Jing
Chen, Yu
Ji, Dongmei
Fan, Li
Chen, Ling
Zhao, Qian
Hu, Pei
Sun, Peng
Jia, Zhongwei
Guo, Jun
Si, Lu
Publication Year :: 2023
Publisher :: figshare, 2023.
Abstract: Additional file 1.

Full Text Access

Tools